Jeffrey D Cirillo is an expert in Infectiology at Texas A&M University (United States). Jeffrey D Cirillo has authored 152 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 630 (community average: 125). How the SLR is computed.

LeadR Profile

Jeffrey D Cirillo Texas A&M University United States
630 ScienceLeadR Reputation 630
Network Map

Infectiology

Subspecialties: Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1991 - 2026

Source: PubMed

Texas A&M University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 152

Citations

Citations: 6 520 1st author: 8 Last author: 63 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Tissue-adhesive hydrogel-MXene biosensor for in situ intraoral TNF-α detection.
PMID 41544161 — hydrogel, polyethylene glycol dimethacrylate, hydrogels, tissue adhesives, biomarkers, adhesives, tissues
Sci Adv20260
Mycobacterium tuberculosis fluorescent and bioluminescent imaging technologies: addressing the issue of sensitivity.
PMID 41164999 — mycobacterium, respiratory tract diseases, respiratory tract infections, tuberculosis, diagnosis, bacteria, mycobacterium tuberculosis
Expert Rev Respir Med20250
Microbicidal mechanisms for light-activated molecular nanomachines in Mycobacterium smegmatis: A model for pathogenic bacteria.
PMID 40893413 — mycobacterium, pharmaceutical preparations, tuberculosis, mycobacterium smegmatis, bacteria, infections
OpenNano20251
Microbicidal Mechanisms for Light-Activated Molecular Nanomachines in Mycobacterium smegmatis: A Model for Pathogenic Bacteria
OpenAlex W4407923369 — mycobacterium, mycobacterium smegmatis, bacteria
OpenNano20250
BCG-Induced DNA Methylation Changes Improve Coronavirus Disease 2019 Vaccine Immunity Without Decreasing the Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
PMID 39872813 — coronavirus, sars-cov-2, vaccines, covid-19 vaccines, severe acute respiratory syndrome, vaccination, dna methylation, covid-19, health personnel, immunity, dna, infections
Open Forum Infect Dis20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 4 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map